標(biāo)題: Titlebook: Dermato-Oncology Study Guide; Essential Text and R Vincent Liu Textbook 2021 Springer Nature Switzerland AG 2021 Dermato-oncology.Paraneopl [打印本頁] 作者: 撒謊 時(shí)間: 2025-3-21 16:11
書目名稱Dermato-Oncology Study Guide影響因子(影響力)
書目名稱Dermato-Oncology Study Guide影響因子(影響力)學(xué)科排名
書目名稱Dermato-Oncology Study Guide網(wǎng)絡(luò)公開度
書目名稱Dermato-Oncology Study Guide網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Dermato-Oncology Study Guide被引頻次
書目名稱Dermato-Oncology Study Guide被引頻次學(xué)科排名
書目名稱Dermato-Oncology Study Guide年度引用
書目名稱Dermato-Oncology Study Guide年度引用學(xué)科排名
書目名稱Dermato-Oncology Study Guide讀者反饋
書目名稱Dermato-Oncology Study Guide讀者反饋學(xué)科排名
作者: overture 時(shí)間: 2025-3-21 21:56
,‘All News Is Fake News’: Discuss,syndromes occur in upwards of 15% of cancer patients, and skin is the second most commonly targeted organ system. Paraneoplastic dermatoses vary considerably in their prevalence and strength of association with characteristic underlying malignancy. Division of dermatoses suspected as paraneoplastic 作者: landfill 時(shí)間: 2025-3-22 01:07
Wie wahr sind wissenschaftliche Tatsachen?egional and/or distant metastases) is apparent at diagnosis in approximately 15% of cases [.]. It is important for the practicing clinician to have a thorough understanding of the epidemiology, pathophysiology, and treatment of melanoma, as endorsement of prevention strategies, proper screening regi作者: 減至最低 時(shí)間: 2025-3-22 07:07
Holm Gero Hümmler,Ulrike Schiesser regardless of their treatments. Many of the therapies used to treat inflammatory skin diseases modulate the immune system. It is important to determine whether dermatologic therapies influence the risk of malignancies in patients with psoriasis and atopic dermatitis. However, assessing the associat作者: 蜈蚣 時(shí)間: 2025-3-22 12:46
Unternehmensumfeld und Weiterbildungion and systemic malignancy is highlighted by a broad spectrum of pathology: (1) Cutaneous infections related to the malignancy itself, its treatment (chemotherapy and/or radiation), or invasive procedures used for diagnosis or treatment; (2) Cutaneous infections related to specific therapies for ma作者: BLINK 時(shí)間: 2025-3-22 15:10 作者: BLINK 時(shí)間: 2025-3-22 17:37 作者: dyspareunia 時(shí)間: 2025-3-22 21:13
https://doi.org/10.1007/978-3-658-37795-3 for targeted and immunotherapies, and describes their corresponding associated dermatologic adverse effects (DAEs) in these settings. For each medication discussed, a clinical synopsis is provided which showcases incidence, natural course, clinical features, and management of potential mucocutaneou作者: CHAFE 時(shí)間: 2025-3-23 05:14 作者: coddle 時(shí)間: 2025-3-23 07:48
https://doi.org/10.1007/978-3-658-37795-3ot recognized by healthcare providers and regulatory bodies. These are often referred to as complementary and alternative medicines (CAMs). The effectiveness of these treatments vary widely, encompassing the spectrum of well established and research-effective off-label use, to questionable use, to a作者: 蘆筍 時(shí)間: 2025-3-23 10:17 作者: 吞沒 時(shí)間: 2025-3-23 15:05
Mit wem diskutiert man und wozu?Surgical procedures remain key diagnostic and therapeutic steps in the proper diagnosis and management of cutaneous malignancy. This chapter reviews surgical considerations necessary for optimizing the surgical approach to cutaneous malignancies.作者: 朝圣者 時(shí)間: 2025-3-23 18:43
Genodermatoses with Malignant Potential,Genodermatoses with malignant potential often manifest cutaneous findings as the presenting feature (Table 1). In most cases, the diagnosis can be made by clinical criteria or genetic testing. Prompt diagnosis is critical to initiate appropriate screening for malignancy.作者: 托人看管 時(shí)間: 2025-3-24 00:57
Surgical Approach to Cutaneous Malignancy with Systemic Implications,Surgical procedures remain key diagnostic and therapeutic steps in the proper diagnosis and management of cutaneous malignancy. This chapter reviews surgical considerations necessary for optimizing the surgical approach to cutaneous malignancies.作者: 松緊帶 時(shí)間: 2025-3-24 06:06
https://doi.org/10.1007/978-3-030-53437-0Dermato-oncology; Paraneoplastic dermatoses; Cutaneous metastases; Drug reactions; Genodermatoses; Malign作者: VEST 時(shí)間: 2025-3-24 08:43 作者: faultfinder 時(shí)間: 2025-3-24 13:08 作者: palette 時(shí)間: 2025-3-24 18:53 作者: artifice 時(shí)間: 2025-3-24 20:47
https://doi.org/10.1007/978-3-8349-8686-3nticancer therapy. Reviewed are strategies and protocols for treating common symptoms and conditions experienced by these patients. Specific anticancer therapeutic classes are addressed in greater detail in the following three chapters.作者: jabber 時(shí)間: 2025-3-24 23:40
Dermatologic Adverse Effects of Anticancer Therapy I: General Principles,nticancer therapy. Reviewed are strategies and protocols for treating common symptoms and conditions experienced by these patients. Specific anticancer therapeutic classes are addressed in greater detail in the following three chapters.作者: patriot 時(shí)間: 2025-3-25 05:06
,‘All News Is Fake News’: Discuss,ulsive clinical-pathologic correlation. Furthermore, metastases of unknown primary site elude definitive classification despite rigorous ancillary histologic and imaging studies. Herein, we review wisdom inherited from nearly a century of clinicopathologic correlation and study of cutaneous metastas作者: infinite 時(shí)間: 2025-3-25 09:14 作者: Basal-Ganglia 時(shí)間: 2025-3-25 13:05 作者: 消音器 時(shí)間: 2025-3-25 18:27
Malignancy Risks of Dermatologic Therapies, in this chapter include oral systemic therapies, phototherapies, and biologic therapies. This chapter will also discuss malignancy risk in special immunosuppressed populations such as organ transplant and HIV patients.作者: Alopecia-Areata 時(shí)間: 2025-3-25 20:27
Textbook 2021gnancy by creating an easy-to-use resource that provides practical tools to recognize skin signs of internal malignancy. Furthermore it helps in anticipating and managing adverse reactions of therapeutics for systemic malignancy, and gives the reader?the opportunity to weigh the risks of malignancy 作者: evince 時(shí)間: 2025-3-26 03:20
signs of internal malignancy. Furthermore it helps in anticipating and managing adverse reactions of therapeutics for systemic malignancy, and gives the reader?the opportunity to weigh the risks of malignancy 978-3-030-53436-3978-3-030-53437-0作者: BUDGE 時(shí)間: 2025-3-26 04:33
Infection, Skin, and Systemic Malignancy,(chemotherapy and/or radiation), or invasive procedures used for diagnosis or treatment; (2) Cutaneous infections related to specific therapies for malignancy; and (3) Infections which predispose to cutaneous malignancy.作者: 厭煩 時(shí)間: 2025-3-26 08:44 作者: Legend 時(shí)間: 2025-3-26 16:15 作者: Volatile-Oils 時(shí)間: 2025-3-26 17:41
Wie wahr sind wissenschaftliche Tatsachen?mens, and appropriate treatment of early stage disease all play a role in preventing the development of advanced disease. For patients who do present with systemic involvement, recent advances in molecular biology and immunology have led to novel therapeutic targets and resultant life-prolonging treatment options.作者: slow-wave-sleep 時(shí)間: 2025-3-26 23:42 作者: defibrillator 時(shí)間: 2025-3-27 02:16
https://doi.org/10.1007/978-3-658-37795-3ctually causing harm. In this chapter we will explore alternate treatments to avoid, those with potential benefits in prevention and treatment of cutaneous malignancy, and those with potential benefits in treating non-oncologic cutaneous problems.作者: ANN 時(shí)間: 2025-3-27 08:01
eview of multidisciplinary concepts critical for the effectiThis book provides clinicians, clinicians-in-training and researchers with a unique rapid-access educational resource on the spectrum of issues at the intersection of skin and malignancy. In it, there is clinical detail provided on how the 作者: 鞭打 時(shí)間: 2025-3-27 12:54
Unternehmensumfeld und Weiterbildung(chemotherapy and/or radiation), or invasive procedures used for diagnosis or treatment; (2) Cutaneous infections related to specific therapies for malignancy; and (3) Infections which predispose to cutaneous malignancy.作者: ATP861 時(shí)間: 2025-3-27 16:20
,Das Problem der “inkompletten” Antik?rper,provided, offering an a overview of incidence, natural course, clinical features, and management of its dermatologic adverse effects. This chapter is designed to assist practitioners in anticipating the dermatologic manifestations of these anticancer therapies and managing any complications should they arise.作者: 雪崩 時(shí)間: 2025-3-27 19:25 作者: Alienated 時(shí)間: 2025-3-28 01:46
,‘All News Is Fake News’: Discuss,he very characteristic neoplasm. For relatively common dermatoses, recognition of a facultative paraneoplastic process rests on astute observation of atypical onset, distribution, or select associated signs and symptoms.作者: Nomogram 時(shí)間: 2025-3-28 03:34 作者: 輕彈 時(shí)間: 2025-3-28 08:38
Systemic Implications of Melanoma,mens, and appropriate treatment of early stage disease all play a role in preventing the development of advanced disease. For patients who do present with systemic involvement, recent advances in molecular biology and immunology have led to novel therapeutic targets and resultant life-prolonging treatment options.作者: Restenosis 時(shí)間: 2025-3-28 11:12
Dermatologic Adverse Effects of Anticancer Therapy IV: Endocrine, Biologic, Radiation and Other Thermatologic adverse effects. For each therapy is provided an overview of incidence, natural course, clinical features, and management of dermatologic adverse effects associated with its therapeutic modality.作者: Landlocked 時(shí)間: 2025-3-28 15:30
Complementary and Alternative Medicine and Dermatooncology,ctually causing harm. In this chapter we will explore alternate treatments to avoid, those with potential benefits in prevention and treatment of cutaneous malignancy, and those with potential benefits in treating non-oncologic cutaneous problems.作者: Obituary 時(shí)間: 2025-3-28 19:50
Textbook 2021 intersection of skin and malignancy. In it, there is clinical detail provided on how the skin reveals systemic malignancy via cutaneous metastases, genodermatoses or paraneoplastic dermatoses. At the same time, it reviews pharmacologic treatment of internal malignancy and how this can result in cut作者: 兵團(tuán) 時(shí)間: 2025-3-28 23:28
Cutaneous Metastases,ed management of the underlying malignancy. Cutaneous metastases are infrequent and may clinically mimic primary neoplastic and non-neoplastic skin disorders; thus, familiarity with the full range of their clinical and pathological presentations is critical to recognition. Patterns of metastasis bas作者: dissolution 時(shí)間: 2025-3-29 03:13
Paraneoplastic Dermatoses and Related Conditions,syndromes occur in upwards of 15% of cancer patients, and skin is the second most commonly targeted organ system. Paraneoplastic dermatoses vary considerably in their prevalence and strength of association with characteristic underlying malignancy. Division of dermatoses suspected as paraneoplastic 作者: 的’ 時(shí)間: 2025-3-29 10:24 作者: 壕溝 時(shí)間: 2025-3-29 15:15 作者: 勉勵(lì) 時(shí)間: 2025-3-29 18:33 作者: 依法逮捕 時(shí)間: 2025-3-29 22:54
Dermatologic Adverse Effects of Anticancer Therapy I: General Principles,nticancer therapy. Reviewed are strategies and protocols for treating common symptoms and conditions experienced by these patients. Specific anticancer therapeutic classes are addressed in greater detail in the following three chapters.作者: Fibrinogen 時(shí)間: 2025-3-30 03:30
Dermatologic Adverse Effects of Anticancer Therapy II: Cytotoxic Agents,w of indications for each drug class as well as profiles of their potential mucocutaneous reactions. For each anticancer agent, a clinical summary is provided, offering an a overview of incidence, natural course, clinical features, and management of its dermatologic adverse effects. This chapter is
